Time course in the development of cerebral vasospasm after experimental subarachnoid hemorrhage: Clinical and neuroradiological assessment of the rat double hemorrhage model

Neurosurgery

Volumn 58, Issue 6, 2006, Pages 1190-1196

  Vatter, Hartmut ^a,b   Weidauer, Stefan ^a   Konczalla, Juergen ^a   Dettmann, Edgar ^a   Zimmermann, Michael ^a   Raabe, Andreas ^a   Preibisch, Christine ^a   Zanella, Friedhelm E ^a   Seifert, Volker ^a  

^a GOETHE UNIVERSITY   (Germany)

^b NONE   (Germany)

Author keywords

Cerebral blood flow; Double hemorrhage model; Rat; Subarachnoid hemorrhage; Vasospasm

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY DIAMETER; ARTICLE; BASILAR ARTERY; BRAIN BLOOD FLOW; BRAIN VASOSPASM; CISTERNA MAGNA; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; DIGITAL SUBTRACTION ANGIOGRAPHY; MALE; MASSETER MUSCLE; NEURORADIOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PERFUSION WEIGHTED IMAGING; PRIORITY JOURNAL; RAT; SCORING SYSTEM; SIMULATION; STATISTICAL SIGNIFICANCE; SUBARACHNOID HEMORRHAGE; VALIDITY;

ANGIOGRAPHY, DIGITAL SUBTRACTION; ANIMALS; BASILAR ARTERY; BLOOD VOLUME; CEREBRAL ANGIOGRAPHY; CEREBROVASCULAR CIRCULATION; MAGNETIC RESONANCE IMAGING; MALE; MASSETER MUSCLE; NERVOUS SYSTEM DISEASES; RATS; RATS, SPRAGUE-DAWLEY; REGIONAL BLOOD FLOW; REPRODUCIBILITY OF RESULTS; SUBARACHNOID HEMORRHAGE; TIME FACTORS; VASOCONSTRICTION; VASOSPASM, INTRACRANIAL;

EID: 33745094951     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.NEU.0000199346.74649.66     Document Type: Article

References (59)

1. Aladag MA, Turkoz Y, Sahna E, Parlakpinar H, Gul M: The attenuation of vasospasm by using a sod mimetic after experimental subarachnoidal haemorrhage in rats. Acta Neurochir (Wien) 145:673-677, 2003.
2. Albers GW: Expanding the window for thrombolytic therapy in acute stroke. The potential role of acute MRI for patient selection. Stroke 30:2230-2237, 1999.
3. Beck J, Raabe A, Lanfermann H, Seifert V, Weidauer S: Tissue at risk concept for endovascular treatment of severe vasospasm after aneurysmal subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry 75:1779-1781, 2004.
4. Bederson JB, Pitts LH, Tsuji M, Nishimura MC, Davis RL, Bartkowski H: Rat middle cerebral artery occlusion: Evaluation of the model and development of a neurologic examination. Stroke 17:472-476, 1986.
5. Boullin DJ, Aitken V, du Boulay GH, Tagari P: The calibre of cerebral arteries of the rat studied by carotid angiography: A model system for studying the aetiology of human cerebral arterial constriction after aneurysmal rupture. Neuroradiology 21:245-252, 1981.
6. Cambj-Sapunar L, Yu M, Harder DR, Roman RJ: Contribution of 5-hydroxytryptamine1B receptors and 20-hydroxyeiscosatetraenoic acid to fall in cerebral blood flow after subarachnoid hemorrhage. Stroke 34:1269-1275, 2003.
7. Clozel M, Watanabe H: BQ-123, a peptidic endothelin ETA receptor antagonist, prevents the early cerebral vasospasm following subarachnoid hemorrhage after intracisternal but not intravenous injection. Life Sci 52:825-834, 1993.
8. Condette-Auliac S, Bracard S, Anxionnat R, Schmitt E, Lacour JC, Braun M, Meloneto J, Cordebar A, Yin L, Picard L: Vasospasm after subarachnoid hemorrhage: Interest in diffusion-weighted MR imaging. Stroke 32:1818-1824, 2001.
9. Delgado TJ, Arbab MA, Diemer NH, Svendgaard NA: Subarachnoid hemorrhage in the rat: Cerebral blood flow and glucose metabolism during the late phase of cerebral vasospasm. J Cereb Blood Flow Metab 6:590-599, 1986.
10. Delgado TJ, Brismar J, Svendgaard NA: Subarachnoid haemorrhage in the rat: Angiography and fluorescence microscopy of the major cerebral arteries. Stroke 16:595-602, 1985.
11. Dittmar MS, Fehm NP, Vatankhah B, Horn M: Ketamine/xylazine anesthesia for radiologic imaging of neurologically impaired rats: Dose response, respiratory depression, management of complications. Comp Med 54:652-655, 2004.
12. Ebisu T, Mori Y, Katsuta K, Fujikawa A, Matsuoka N, Aoki I, Umeda M, Naruse S, Tanaka C: Neuroprotective effects of an immunosuppressant agent on diffusion/perfusion mismatch in transient focal ischemia. Magn Reson Med 51:1173-1180, 2004.
13. Findlay JM, Deagle GM: Causes of morbidity and mortality following intracranial aneurysm rupture. Can J Neurol Sci 25:209-215, 1998.
14. Granstam E, Granstam SO: Involvement of nitric oxide in the regulation of regional hemodynamics in streptozotocin-diabetic rats. Physiol Res 52:159-169, 2003.
15. Grasso G: An overview of new pharmacological treatments for cerebrovascular dysfunction after experimental subarachnoid hemorrhage. Brain Res Brain Res Rev 44:49-63, 2004.
16. Hertel F, Walter C, Bettag M, Morsdorf M: Perfusion-weighted magnetic resonance imaging in patients with vasospasm: A useful new tool in the management of patients with subarachnoid hemorrhage. Neurosurgery 56:28-35, 2005.
17. Hop JW, Rinkel GJ, Algra A, van Gijn J: Case-fatality rates and functional outcome after subarachnoid hemorrhage: A systematic review. Stroke 28:660-664, 1997.
18. Ikeda K: Cerebral angiography of the rat. Technical note. J Neurosurg 49:319-321, 1978.
19. Jackowski A, Crockard A, Burnstock G, Russell RR, Kristek F: The time course of intracranial pathophysiological changes following experimental subarachnoid haemorrhage in the rat. J Cereb Blood Flow Metab 10:835-849, 1990.
20. Jiang Q, Zhang RL, Zhang ZG, Ewing JR, Divine GW, Chopp M: Diffusion-, T2-, perfusion-weighted nuclear magnetic resonance imaging of middle cerebral artery embolic stroke and recombinant tissue plasminogen activator intervention in the rat. J Cereb Blood Flow Metab 18:758-767, 1998.
21. Leclerc X, Fichten A, Gauvrit JY, Riegel B, Steinling M, Lejeune JP, Pruvo JP: Symptomatic vasospasm after subarachnoid haemorrhage: Assessment of brain damage by diffusion and perfusion-weighted MRI and single-photon emission computed tomography. Neuroradiology 44:610-616, 2002.
22. Lei H, Grinberg O, Nwaigwe CI, Hou HG, Williams H, Swartz HM, Dunn JF: The effects of ketamine-xylazine anesthesia on cerebral blood flow and oxygenation observed using nuclear magnetic resonance perfusion imaging and electron paramagnetic resonance oximetry. Brain Res 913:174-179, 2001.
23. Liu Y, Karonen JO, Vanninen RL, Ostergaard L, Roivainen R, Nuutinen J, Perkio J, Kononen M, Hamalainen A, Vanninen EJ, Soimakallio S, Kuikka JT, Aronen HJ: Cerebral hemodynamics in human acute ischemic stroke: A study with diffusion- and perfusion-weighted magnetic resonance imaging and SPECT. J Cereb Blood Flow Metab 20:910-920, 2000.
24. Longo M, Blandino A, Ascenti G, Ricciardi GK, Granata F, Vinci S: Cerebral angiography in the rat with mammographic equipment: A simple, cost-effective method for assessing vasospasm in experimental subarachnoid haemorrhage. Neuroradiology 44:689-694, 2002.
25. Luedemann W, Brinker T, Schuhmann MU, von Brenndorf AI, Samii M: Direct magnification technique for cerebral angiography in the rat. Invest Radiol 33:421-424, 1998.
26. Meguro T, Clower BR, Carpenter R, Parent AD, Zhang JH: Improved rat model for cerebral vasospasm studies. Neurol Res 23:761-766, 2001.
27. Megyesi JF, Vollrath B, Cook DA, Findlay JM: In vivo animal models of cerebral vasospasm: A review. Neurosurgery 46:448-460, 2000.
28. Mihara F, Kuwabara Y, Yoshiura T, Tanaka A, Kaneko K, Sasaki M, Honda H, Matsushima T: Semi-quantitative CBF and CBF ratios obtained using perfusion-weighted MR imaging. Neuroreport 14:725-727, 2003.
29. Miyagi Y, Carpenter RC, Meguro T, Parent AD, Zhang JH: Upregulation of rho A and rho kinase messenger RNAs in the basilar artery of a rat model of subarachnoid hemorrhage. J Neurosurg 93:471-476, 2000.
30. Naveri L, Stromberg C, Saavedra JM: Angiotensin IV reverses the acute cerebral blood flow reduction after experimental subarachnoid hemorrhage in the rat. J Cereb Blood Flow Metab 14:1096-1099, 1994.
31. Nikaido H, Tsunoda H, Nishimura Y, Kirino T, Tanaka T: Potential role for heat shock protein 72 in antagonizing cerebral vasospasm after rat subarachnoid hemorrhage. Circulation 110:1839-1846, 2004.
32. Ono S, Date I, Nakajima M, Onoda K, Ogihara K, Shiota T, Asari S, Ninomiya Y, Yabuno N, Ohmoto T: Three-dimensional analysis of vasospastic major cerebral arteries in rats with the corrosion cast technique. Stroke 28:1631-1637, 1997.
33. Ono S, Date I, Onoda K, Ohmoto T: Time course of the diameter of the major cerebral arteries after subarachnoid hemorrhage using corrosion cast technique. Neurol Res 25:383-389, 2003.
34. Ostergaard L, Sorensen AG, Kwong KK, Weisskoff RM, Gyldensted C, Rosen BR: High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part II: Experimental comparison and preliminary results. Magn Reson Med 36:726-736, 1996.
35. Ostergaard L, Weisskoff RM, Chesler DA, Gyldensted C, Rosen BR: High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I: Mathematical approach and statistical analysis. Magn Reson Med 36:715-725, 1996.
36. Palmer GM, Cairns BE, Berkes SL, Dunning PS, Taylor GA, Berde CB: The effects of lidocaine and adrenergic agonists on rat sciatic nerve and skeletal muscle blood flow in vivo. Anesth Analg 95:1080-6, table, 2002.
37. Perez-Trepichio AD, Xue M, Ng TC, Majors AW, Furlan AJ, Awad IA, Jones SC: Sensitivity of magnetic resonance diffusion-weighted imaging and regional relationship between the apparent diffusion coefficient and cerebral blood flow in rat focal cerebral ischemia. Stroke 26:667-674, 1995.
38. Perkins CJ, Kahya E, Roque CT, Roche PE, Newman GC: Fluid-attenuated inversion recovery and diffusion- and perfusion-weighted MRI abnormalities in 117 consecutive patients with stroke symptoms. Stroke 32:2774-2781, 2001.
39. Prunell GF, Mathiesen T, Svendgaard NA: Experimental subarachnoid hemorrhage: Cerebral blood flow and brain metabolism during the acute phase in three different models in the rat. Neurosurgery 54:426-436, 2004.
40. Raabe A, Zimmermann M, Setzer M, Vatter H, Berketeld J, Seifert V: Effect of intraventricular sodium nitroprusside on cerebral hemodynamics and oxygenation in poor-grade aneurysm patients with severe, medically refractory vasospasm. Neurosurgery 50:1006-1013, 2002.
41. Rabinstein AA, Pichelmann MA, Friedman JA, Piepgras DG, Nichols DA, McIver JI, Toussaint LG 3rd, McClelland RL, Fulgham JR, Meyer FB, Atkinson JL, Wijdicks EF: Symptomatic vasospasm and outcomes following aneurysmal subarachnoid hemorrhage: A comparison between surgical repair and endovascular coil occlusion. J Neurosurg 98:319-325, 2003.
42. Rordorf G, Koroshetz WJ, Copen WA, Gonzalez G, Yamada K, Schaefer PW, Schwamm LH, Ogilvy CS, Sorensen AG: Diffusion- and perfusion-weighted imaging in vasospasm after subarachnoid hemorrhage. Stroke 30:599-605, 1999.
43. Rousselle CH, Letauconnier JM, Allen DD: Evaluation of anesthetic effects on parameters for the in situ rat brain perfusion technique. Neurosci Lett 257:139-142, 1998.
44. Rowe J, Blamire AM, Domingo Z, Moody V, Molyneux A, Byrne J, Cadoux-Hudson T, Radda G: Discrepancies between cerebral perfusion and metabolism after subarachnoid haemorrhage: A magnetic resonance approach. J Neurol Neurosurg Psychiatry 64:98-103, 1998.
45. Ryba MS, Gordon-Krajcer W, Walski M, Chalimoniuk M, Chrapusta SJ: Hydroxylamine attenuates the effects of simulated subarachnoid hemorrhage in the rat brain and improves neurological outcome. Brain Res 850:225-233, 1999.
46. Saida A, Ito H, Shibuya T, Watanabe Y: Time-course alterations of monoamine levels and cerebral blood flow in brain regions after subarachnoid hemorrhage in rats. Brain Res Bull 43:69-80, 1997.
47. Satoh M, Parent AD, Zhang JH: Inhibitory effect with antisense mitogen-activated protein kinase oligodeoxynucleotide against cerebral vasospasm in rats. Stroke 33:775-781, 2002.
48. Solomon RA, Antunes JL, Chen RY, Bland L, Chien S: Decrease in cerebral blood flow in rats after experimental subarachnoid hemorrhage: A new animal model. Stroke 16:58-64, 1985.
49. Solomon RA, Lovitz RL, Hegemann MT, Schuessler GB, Young WL, Chien S: Regional cerebral metabolic activity in the rat following experimental subarachnoid hemorrhage. J Cereb Blood Flow Metab 7:193-198, 1987.
50. Suzuki H, Kanamaru K, Tsunoda H, Inada H, Kuroki M, Sun H, Waga S, Tanaka T: Heme oxygenase-1 gene induction as an intrinsic regulation against delayed cerebral vasospasm in rats. J Clin Invest 104:59-66, 1999.
51. Tatlisumak T, Li F: Use of diffusion- and perfusion-weighted magnetic resonance imaging in drug development for ischemic stroke. Curr Drug Targets CNS Neurol Disord 2:131-141, 2003.
52. Thomas JE, McGinnis G: Safety of intraventricular sodium nitroprusside and thiosulfate for the treatment of cerebral vasospasm in the intensive care unit setting. Stroke 33:486-492, 2002.
53. Trandafir CC, Nishihashi T, Wang A, Murakami S, Ji X, Kurahashi K: Participation of vasopressin in the development of cerebral vasospasm in a rat model of subarachnoid haemorrhage. Clin Exp Pharmacol Physiol 31:261-266, 2004.
54. Vajkoczy P, Meyer B, Weidauer S, Raabe A, Thome C, Ringel F, Breu V, Schmiedek P: Clazosentan (AXV-034343), a selective endothelin A receptor antagonist, in the prevention of cerebral vasospasm following severe aneurysmal subarachnoid hemorrhage: Results of a randomized, double-blind, placebo-controlled, multicenter phase Ha study. J Neurosurg 103:9-17, 2005.
55. Vatter H, Zimmermann M, Seifert V, Schilling L: Experimental approaches to evaluate endothelin-A receptor antagonists. Methods Find Exp Clin Pharmacol 26:277-286, 2004.
56. Verlooy J, Van Reempts J, Haseldonckx M, Borgers M, Selosse P: The course of vasospasm following subarachnoid haemorrhage in rats. A vertebrobasilar angiographic study. Acta Neurochir (Wien) 117:48-52, 1992.
57. Walsh EG, Minematsu K, Leppo J, Moore SC: Radioactive microsphere validation of a volume localized continuous saturation perfusion measurement. Magn Reson Med 31:147-153, 1994.
58. Wittsack HJ, Ritzl A, Modder U: User friendly analysis of MR investigations of the cerebral perfusion: Windows-based image processing. Rofo 174:742-746, 2002.
59. Yamamoto S, Nishizawa S, Tsukada H, Kakiuchi T, Yokoyama T, Ryu H, Uemura K: Cerebral blood flow autoregulation following subarachnoid hemorrhage in rats: Chronic vasospasm shifts the upper and lower limits of the autoregulatory range toward higher blood pressures. Brain Res 782:194-201, 1998.